Cipla witnesses 3 senior-level exits including India biz CEO

Drug firm Cipla has witnessed three senior-level exits, including that of the company's Executive Vice-President and CEO for India business Nikhil Chopra. The other two executives are Nikhil Lalwani, head of India prescription business, and Kunal Khanna, cluster head of chronic and emerging business development and portfolio.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news